Published in Eur J Neurosci on September 01, 2002
Modulation of voltage-gated ion channels in rat retinal ganglion cells mediated by somatostatin receptor subtype 4. J Neurophysiol (2010) 0.91
Neuropeptides as targets for the development of anticonvulsant drugs. Mol Neurobiol (2014) 0.90
Somatostatinergic systems: an update on brain functions in normal and pathological aging. Front Endocrinol (Lausanne) (2012) 0.89
Somatostatin: an endogenous antiepileptic. Mol Cell Endocrinol (2007) 0.89
Neuronal plasticity in animal models and the epileptic human hippocampus. Epilepsia (2009) 0.87
Hippocampal SSTR4 somatostatin receptors control the selection of memory strategies. Psychopharmacology (Berl) (2008) 0.85
Anxiolytic and antidepressant actions of somatostatin: the role of sst2 and sst3 receptors. Psychopharmacology (Berl) (2009) 0.82
Accelerated kindling development in mu-opioid receptor deficient mice. Naunyn Schmiedebergs Arch Pharmacol (2004) 0.81
Current prospects and challenges for epilepsy gene therapy. Exp Neurol (2011) 0.80
Protective role of somatostatin receptor 2 against retinal degeneration in response to hypoxia. Naunyn Schmiedebergs Arch Pharmacol (2012) 0.79
Relative expression of mRNA for the somatostatin receptors in the caudate putamen of C57BL/6J and 129P3/J mice: strain and heroin effects. Brain Res (2010) 0.78
Somatostatin stimulates the migration of hepatic oval cells in the injured rat liver. Liver Int (2011) 0.77
Somatostatin type-2 receptor activation inhibits glutamate release and prevents status epilepticus. Neurobiol Dis (2013) 0.77
Somatostatin coupling to adenylyl cyclase activity in the mouse retina. Naunyn Schmiedebergs Arch Pharmacol (2004) 0.76
Roles of Hippocampal Somatostatin Receptor Subtypes in Stress Response and Emotionality. Neuropsychopharmacology (2016) 0.75
Effect of octreotide on human pancreatic cancer cells after transfected with somatostatin receptor type 2 gene. World J Gastroenterol (2004) 0.75
Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J Neurosci (2003) 3.38
The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48
APOE and Alzheimer disease: a major gene with semi-dominant inheritance. Mol Psychiatry (2011) 2.31
Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology. Mol Psychiatry (2013) 2.25
Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. Proc Natl Acad Sci U S A (2000) 2.08
Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus. Eur J Neurosci (2000) 2.00
(+/-)[125Iodo] cyanopindolol, a new ligand for beta-adrenoceptors: identification and quantitation of subclasses of beta-adrenoceptors in guinea pig. Naunyn Schmiedebergs Arch Pharmacol (1981) 1.99
Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin. Eur J Pharmacol (1985) 1.91
Classification and nomenclature of somatostatin receptors. Trends Pharmacol Sci (1995) 1.90
The binding of serotonergic ligands to the porcine choroid plexus: characterization of a new type of serotonin recognition site. Eur J Pharmacol (1984) 1.79
Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT1B binding sites. Naunyn Schmiedebergs Arch Pharmacol (1986) 1.70
Species differences in the pharmacology of terminal 5-HT autoreceptors in mammalian brain. Trends Pharmacol Sci (1989) 1.63
A proposed new nomenclature for 5-HT receptors. Trends Pharmacol Sci (1993) 1.59
Muscle testing response to provocative vertebral challenge and spinal manipulation: a randomized controlled trial of construct validity. J Manipulative Physiol Ther (1994) 1.57
The IL-1beta system in epilepsy-associated malformations of cortical development. Neurobiol Dis (2006) 1.56
Factors associated with healthy aging: the cardiovascular health study. J Am Geriatr Soc (2001) 1.51
5-Hydroxytryptamine (5-HT)-induced endothelium-dependent relaxation of pig coronary arteries is mediated by 5-HT receptors similar to the 5-HT1D receptor subtype. J Pharmacol Exp Ther (1990) 1.48
Localization of 5-HT1B, 5-HT1D alpha, 5-HT1E and 5-HT1F receptor messenger RNA in rodent and primate brain. Neuropharmacology (1994) 1.46
International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. IX. Recommendations on terms and symbols in quantitative pharmacology. Pharmacol Rev (1995) 1.45
Region-specific transcriptional changes following the three antidepressant treatments electro convulsive therapy, sleep deprivation and fluoxetine. Mol Psychiatry (2006) 1.42
Effect of mild hypothermia on cerebral oxygen uptake during gradual cerebral perfusion pressure decrease in piglets. Crit Care Med (2000) 1.40
Centrally acting hypotensive agents with affinity for 5-HT1A binding sites inhibit forskolin-stimulated adenylate cyclase activity in calf hippocampus. Br J Pharmacol (1988) 1.36
Cellular biology of somatostatin receptors. Neuropeptides (2001) 1.32
P1 aspartate-based peptide alpha-((2,6-dichlorobenzoyl)oxy)methyl ketones as potent time-dependent inhibitors of interleukin-1 beta-converting enzyme. J Med Chem (1994) 1.30
Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acid. Neurosci Lett (1984) 1.29
Can practice guidelines safely reduce hospital length of stay? Results from a multicenter interventional study. Am J Med (1998) 1.26
Molecular pharmacology of 5-HT1D recognition sites: radioligand binding studies in human, pig and calf brain membranes. Naunyn Schmiedebergs Arch Pharmacol (1988) 1.26
Acute induction of epileptiform discharges by pilocarpine in the in vitro isolated guinea-pig brain requires enhancement of blood-brain barrier permeability. Neuroscience (2007) 1.25
Abdominal compartment syndrome. The Nashville experience. Surg Clin North Am (1997) 1.25
Somatostatin and dementia in Parkinson's disease. Brain Res (1983) 1.25
mGluR7 facilitates extinction of aversive memories and controls amygdala plasticity. Mol Psychiatry (2007) 1.24
Somatostatin in the central nervous system: physiology and pathological modifications. Prog Neurobiol (1986) 1.24
siRNA-mediated knockdown of the serotonin transporter in the adult mouse brain. Mol Psychiatry (2005) 1.23
Serotonin receptors in the human brain. II. Characterization and autoradiographic localization of 5-HT1C and 5-HT2 recognition sites. Brain Res (1986) 1.22
Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease. Mol Psychiatry (2012) 1.20
Deficits in memory and hippocampal long-term potentiation in mice with reduced calbindin D28K expression. Proc Natl Acad Sci U S A (1996) 1.19
The 5-hydroxytryptamine 5-HT1D receptor subtype is negatively coupled to adenylate cyclase in calf substantia nigra. Naunyn Schmiedebergs Arch Pharmacol (1988) 1.16
Molecular pharmacology and biology of 5-HT1C receptors. Trends Pharmacol Sci (1988) 1.16
Examining landscape factors influencing relative distribution of mosquito genera and frequency of virus infection. Ecohealth (2009) 1.16
5-HT1A-receptors mediate stimulation of adenylate cyclase in rat hippocampus. Naunyn Schmiedebergs Arch Pharmacol (1986) 1.16
Interaction of arylpiperazines with 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D receptors: do discriminatory 5-HT1B receptor ligands exist? Naunyn Schmiedebergs Arch Pharmacol (1989) 1.15
Molecular pharmacology of somatostatin-receptor subtypes. Ann N Y Acad Sci (1994) 1.15
Status epilepticus induces time-dependent neuronal and astrocytic expression of interleukin-1 receptor type I in the rat limbic system. Neuroscience (2005) 1.14
Cloning and functional characterization of the rat stomach fundus serotonin receptor. EMBO J (1992) 1.14
Autoradiographic characterisation and localisation of 5-HT1D compared to 5-HT1B binding sites in rat brain. Naunyn Schmiedebergs Arch Pharmacol (1993) 1.13
The grey mouse lemur: a non-human primate model for ageing studies. Ageing Res Rev (2011) 1.13
5-Hydroxytryptamine 5-HT1B and 5-HT1D receptors mediating inhibition of adenylate cyclase activity. Pharmacological comparison with special reference to the effects of yohimbine, rauwolscine and some beta-adrenoceptor antagonists. Naunyn Schmiedebergs Arch Pharmacol (1989) 1.13
Detecting nonlinearity and phase synchronization with surrogate data. IEEE Eng Med Biol Mag (1999) 1.13
Altered expression of GABA(A) and GABA(B) receptor subunit mRNAs in the hippocampus after kindling and electrically induced status epilepticus. Neuroscience (2005) 1.12
Angiotensin II and dopamine modulate both cAMP and inositol phosphate productions in anterior pituitary cells. Involvement in prolactin secretion. J Biol Chem (1986) 1.11
Somatostatin receptors 2 and 5 are the major somatostatin receptors in insulinomas: an in vivo and in vitro study. J Clin Endocrinol Metab (2003) 1.11
ATP-modulated K+ channels sensitive to antidiabetic sulfonylureas are present in adenohypophysis and are involved in growth hormone release. Proc Natl Acad Sci U S A (1993) 1.11
Pharmacological blockade of IL-1β/IL-1 receptor type 1 axis during epileptogenesis provides neuroprotection in two rat models of temporal lobe epilepsy. Neurobiol Dis (2013) 1.10
Comparative distribution of mRNA encoding the growth hormone secretagogue-receptor (GHS-R) in Microcebus murinus (Primate, lemurian) and rat forebrain and pituitary. J Comp Neurol (2001) 1.10
How selective is GR 43175? Interactions with functional 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D receptors. Naunyn Schmiedebergs Arch Pharmacol (1989) 1.10
EMK protein kinase-null mice: dwarfism and hypofertility associated with alterations in the somatotrope and prolactin pathways. Dev Biol (1999) 1.10
The beta-adrenergic receptor in human lymphocytes: subclassification by the use of a new radio-ligand, (+/-)-125 Iodocyanopindolol. Life Sci (1981) 1.09
Adenosine receptor ligands: potential as therapeutic agents in asthma and COPD. Pulm Pharmacol Ther (1999) 1.09
IL-9/IL-9 receptor signaling selectively protects cortical neurons against developmental apoptosis. Cell Death Differ (2008) 1.09
Peptide folding induces high and selective affinity of a linear and small beta-peptide to the human somatostatin receptor 4. J Med Chem (2001) 1.08
5-HT1-like receptors mediate 5-hydroxytryptamine-induced contraction of guinea-pig isolated iliac artery. Br J Pharmacol (1991) 1.07
Somatostatin receptors, adenylate cyclase activity, and growth hormone (GH) response to octreotide in GH-secreting adenomas. J Clin Endocrinol Metab (1993) 1.07
The interposito-rubrospinal system. Anatomical tracing of a motor control pathway in the rat. Neurosci Res (1987) 1.07
Fetal heart rate variability reveals differential dynamics in the intrauterine development of the sympathetic and parasympathetic branches of the autonomic nervous system. Physiol Meas (2009) 1.06
Interleukin-1 type 1 receptor/Toll-like receptor signalling in epilepsy: the importance of IL-1beta and high-mobility group box 1. J Intern Med (2011) 1.06
Is the sumatriptan (GR 43175)-induced endothelium-dependent relaxation of pig coronary arteries mediated by 5-HT1D receptors? Eur J Pharmacol (1989) 1.05
Characterization of the 5-HT1B recognition site in rat brain: binding studies with (-)[125I]iodocyanopindolol. Eur J Pharmacol (1985) 1.05
Serotonin receptors in the human brain. I. Characterization and autoradiographic localization of 5-HT1A recognition sites. Apparent absence of 5-HT1B recognition sites. Brain Res (1986) 1.05
Chromatographic and biological properties of immunoreactive somatostatin in hypothalamic and extrahypothalamic brain regions of the rat. Endocrinology (1979) 1.04
Localization of the 5-hydroxytryptamine2C receptor protein in human and rat brain using specific antisera. Neuropharmacology (1995) 1.04
Loss of somatostatin-like immunoreactivity in the frontal cortex of Alzheimer patients carrying the apolipoprotein epsilon 4 allele. Neurosci Lett (1998) 1.04
The pharmacological properties of the presynaptic serotonin autoreceptor in the pig brain cortex conform to the 5-HT1D receptor subtype. Naunyn Schmiedebergs Arch Pharmacol (1989) 1.03
Central 5-HT1A receptors and the mechanism of the central hypotensive effect of (+)8-OH-DPAT, DP-5-CT, R28935, and urapidil. J Cardiovasc Pharmacol (1988) 1.03
The neurobiology of somatostatin. Crit Rev Neurobiol (1994) 1.03
Agonist/antagonist interactions with cloned human 5-HT1A receptors: variations in intrinsic activity studied in transfected HeLa cells. Naunyn Schmiedebergs Arch Pharmacol (1992) 1.02
In vivo and in vitro effects of ghrelin/motilin-related peptide on growth hormone secretion in the rat. Neuroendocrinology (2001) 1.02
Binding characteristics of (+)-, (+/-)- and (-)-[125iodo] cyanopindolol to guinea-pig left ventricle membranes. Naunyn Schmiedebergs Arch Pharmacol (1982) 1.02
Subcellular distribution of radioimmunoassayable somatostatin in rat brain. Brain Res (1977) 1.01
Ground-state fidelity and bipartite entanglement in the Bose-Hubbard model. Phys Rev Lett (2007) 1.01
Anxiety and increased 5-HT1A receptor response in NCAM null mutant mice. J Neurobiol (1999) 1.00
A critical role for the glial-derived neuromodulator D-serine in the age-related deficits of cellular mechanisms of learning and memory. Aging Cell (2006) 1.00
Mesulergine, a selective serotonin-2 ligand in the rat cortex, does not label these receptors in porcine and human cortex: evidence for species differences in brain serotonin-2 receptors. Eur J Pharmacol (1984) 1.00
Extended radioligand binding profile of iloperidone: a broad spectrum dopamine/serotonin/norepinephrine receptor antagonist for the management of psychotic disorders. Neuropsychopharmacology (2001) 1.00
Seizure susceptibility and epileptogenesis are decreased in transgenic rats overexpressing neuropeptide Y. Neuroscience (2002) 1.00
Somatostatin, neuropeptide Y, neurokinin B and cholecystokinin immunoreactivity in two chronic models of temporal lobe epilepsy. Neuroscience (1995) 1.00
Septo-hippocampal and other medial septum-diagonal band neurons: electrophysiological and pharmacological properties. Brain Res (1984) 1.00
Presynaptic and postsynaptic GABAB receptors of neocortical neurons of the rat in vitro: differences in pharmacology and ionic mechanisms. Synapse (1997) 1.00
Alignment of receptor nomenclature with the human genome: classification of 5-HT1B and 5-HT1D receptor subtypes. Trends Pharmacol Sci (1996) 0.99
5-hydroxytryptamine3 receptors in the human brain: autoradiographic visualization using [3H]ICS 205-930. Neuroscience (1989) 0.99
Age-related alterations of GABAergic input to CA1 pyramidal neurons and its control by nicotinic acetylcholine receptors in rat hippocampus. Neuroscience (2006) 0.98
Unveiling an exceptional zymogen: the single-chain form of tPA is a selective activator of NMDA receptor-dependent signaling and neurotoxicity. Cell Death Differ (2012) 0.98
Effects of acute high-altitude exposure on body fluids. Fed Proc (1969) 0.97
Binding of simultaneously administered inorganic selenium and mercury to a rat plasma protein. Proc Soc Exp Biol Med (1974) 0.97